PT1007096E - Complexo de silicato de arginina inositol e a sua utilizacao - Google Patents

Complexo de silicato de arginina inositol e a sua utilizacao

Info

Publication number
PT1007096E
PT1007096E PT98905010T PT98905010T PT1007096E PT 1007096 E PT1007096 E PT 1007096E PT 98905010 T PT98905010 T PT 98905010T PT 98905010 T PT98905010 T PT 98905010T PT 1007096 E PT1007096 E PT 1007096E
Authority
PT
Portugal
Prior art keywords
pct
arginine
silicate
complex
inositol
Prior art date
Application number
PT98905010T
Other languages
English (en)
Portuguese (pt)
Inventor
Mark Mccarty
Jan Zielinski
Original Assignee
Nutrition 21
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nutrition 21 filed Critical Nutrition 21
Publication of PT1007096E publication Critical patent/PT1007096E/pt

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/695Silicon compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/02Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • A61P19/08Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/04Esters of silicic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Epidemiology (AREA)
  • Urology & Nephrology (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Vascular Medicine (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Silicates, Zeolites, And Molecular Sieves (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PT98905010T 1997-02-12 1998-02-11 Complexo de silicato de arginina inositol e a sua utilizacao PT1007096E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/799,784 US5707970A (en) 1997-02-12 1997-02-12 Arginine silicate complex and use thereof

Publications (1)

Publication Number Publication Date
PT1007096E true PT1007096E (pt) 2004-03-31

Family

ID=25176739

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98905010T PT1007096E (pt) 1997-02-12 1998-02-11 Complexo de silicato de arginina inositol e a sua utilizacao

Country Status (16)

Country Link
US (3) US5707970A (https=)
EP (1) EP1007096B1 (https=)
JP (1) JP2001512443A (https=)
KR (1) KR20000070977A (https=)
CN (1) CN1182873C (https=)
AT (1) ATE251914T1 (https=)
AU (1) AU722975B2 (https=)
BR (1) BR9807675A (https=)
CA (1) CA2279233A1 (https=)
DE (1) DE69819016T2 (https=)
DK (1) DK1007096T3 (https=)
ES (1) ES2209112T3 (https=)
HU (1) HUP0001998A3 (https=)
IL (1) IL130925A0 (https=)
PT (1) PT1007096E (https=)
WO (1) WO1998034647A1 (https=)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5707970A (en) 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof
US20020068365A1 (en) * 1998-07-28 2002-06-06 Eric H. Kuhrts Controlled release nitric oxide producing agents
AU2001281337A1 (en) * 2000-07-24 2002-02-05 Nutrition 21, Inc. Arginine saccharate and use thereof
US6552074B2 (en) * 2000-11-16 2003-04-22 Fukumi Morishige Arginine/ascorbic acid mixed powder as an oral supplement
TWI283427B (en) * 2001-07-12 2007-07-01 Semiconductor Energy Lab Display device using electron source elements and method of driving same
US7147661B2 (en) * 2001-12-20 2006-12-12 Boston Scientific Santa Rosa Corp. Radially expandable stent
EP1467679B1 (en) * 2001-12-20 2015-11-04 TriVascular, Inc. Advanced endovascular graft
EP1534302A4 (en) * 2002-08-22 2009-01-07 Nutrition 21 Inc ARGININILICATE / INOSITOL COMPLEX AND ITS USE
US6803456B1 (en) * 2003-08-13 2004-10-12 Rutherford Chemicals Llc Process for the production of arginine-silicate complex
US7803178B2 (en) * 2004-01-30 2010-09-28 Trivascular, Inc. Inflatable porous implants and methods for drug delivery
CA2558573A1 (en) * 2004-03-11 2005-09-22 Trivascular, Inc. Modular endovascular graft
CN101035512B (zh) * 2004-08-12 2012-01-18 昌达生物科技公司 用于生物活性化合物可控制释放递送的药物组合物
US7919620B2 (en) * 2005-06-01 2011-04-05 Coral Biotech Kabushiki Kaisha Agent for suppressing blood pressure elevation
ITMI20060677A1 (it) * 2006-04-06 2007-10-07 Damor Farmaceutici Profarmaci dell'arginina ad elevata attivita'terapeutica
KR20090098783A (ko) * 2006-09-21 2009-09-17 토시키 오구로 경조직 재생 촉진제
ES2841379T3 (es) 2007-03-13 2021-07-08 Jds Therapeutics Llc Procedimientos y composiciones para la liberación sostenida de cromo
WO2009002867A2 (en) 2007-06-26 2008-12-31 Nutrition 21, Inc. Multiple unit dosage form having a therapeutic agents in combination with a nutritional supplement
GB0805279D0 (en) 2008-03-20 2008-04-30 Univ Nottingham Trent Food supplement
WO2012035364A1 (en) 2010-09-15 2012-03-22 Creogen D.O.O. Stabilized solution of ortho-silicic acid, its preparation and use
AU2012223282B2 (en) 2011-03-01 2017-02-02 Nutrition 21, Llc Compositions of insulin and chromium for the treatment and prevention of diabetes, hypoglycemia and related disorders
US11191735B2 (en) 2015-03-13 2021-12-07 Nutrition 21, Llc Arginine silicate for periodontal disease
US20170000809A1 (en) * 2015-06-30 2017-01-05 Jds Therapeutics, Llc Arginine silicate inositol for improving cognitive function
EP3322661B1 (en) 2015-07-13 2022-03-02 Otis Elevator Company Deterrent device inhibition key
US20170135969A1 (en) 2015-11-12 2017-05-18 Jds Therapeutics, Llc Topical arginine-silicate-inositol for wound healing
CA3014308A1 (en) 2016-02-11 2017-08-17 Nutrition 21, Llc Chromium containing compositions for improving health and fitness
CN109890384A (zh) 2016-09-01 2019-06-14 Jds治疗有限公司 生物素镁组合物和使用方法
MX2021005213A (es) 2018-11-02 2021-09-08 Nutrition 21 Llc Composiciones que contienen complejos de silicato de arginina estabilizado con inositol y inositol para mejorar funciones cognitivas en jugadores de videojuegos.
IL294021A (en) 2019-12-16 2022-08-01 Nutrition 21 Llc Methods of production of arginine-silicate complexes
US20250024860A1 (en) * 2021-11-12 2025-01-23 Nutrition21, LLC Compositions and methods for treating or preventing myopathy in poultry
CN118206406B (zh) * 2024-03-20 2025-08-15 山东农业大学 精氨酸硅酸盐肌醇络合物在提高作物果实品质中的应用

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3337403A (en) * 1963-09-05 1967-08-22 Hoffmann La Roche Stable and palatable pharmaceutical compositions
US4297349A (en) * 1980-04-15 1981-10-27 Sandoz, Inc. Silicon-bearing carboxylic acids and amides
US4385052A (en) * 1981-07-20 1983-05-24 International Plant Research Institute, Inc. Use of trialkylsilyl-6-aminonicotinamides for the treatment of psoriasis
FR2610522B1 (fr) * 1987-02-06 1989-08-18 Gueyne Jean Produit therapeutique a base de derives organiques du silicium
US5250569A (en) * 1991-04-22 1993-10-05 Godfrey Science & Design, Inc. Amino acid flavorings of aluminum astringent for oral use
US5622980A (en) * 1993-08-17 1997-04-22 Applied Analytical Industries, Inc. Oral compositions of H2-antagonists
FR2745498A1 (fr) * 1996-02-29 1997-09-05 Giroux Jean Marc Composition pur augmenter conjointement la tolerance biologique et l'efficacite amincissante des produits hyperproteines hypocaloriques destines au traitement de l'obesite
US5707970A (en) * 1997-02-12 1998-01-13 Nutrition 21 Arginine silicate complex and use thereof

Also Published As

Publication number Publication date
US6156735A (en) 2000-12-05
AU722975B2 (en) 2000-08-17
HUP0001998A3 (en) 2002-01-28
KR20000070977A (ko) 2000-11-25
DK1007096T3 (da) 2003-12-01
JP2001512443A (ja) 2001-08-21
DE69819016D1 (de) 2003-11-20
AU6273798A (en) 1998-08-26
DE69819016T2 (de) 2004-04-29
ES2209112T3 (es) 2004-06-16
US6344444B1 (en) 2002-02-05
BR9807675A (pt) 2000-02-15
ATE251914T1 (de) 2003-11-15
IL130925A0 (en) 2001-01-28
EP1007096A1 (en) 2000-06-14
CA2279233A1 (en) 1998-08-13
HUP0001998A2 (hu) 2000-10-28
US5707970A (en) 1998-01-13
CN1182873C (zh) 2005-01-05
EP1007096B1 (en) 2003-10-15
WO1998034647A1 (en) 1998-08-13
CN1246801A (zh) 2000-03-08

Similar Documents

Publication Publication Date Title
PT1007096E (pt) Complexo de silicato de arginina inositol e a sua utilizacao
ATE437393T1 (de) Verfahren und vorrichtung zur bereitstellung eines entkoppelten leistungsverwaltungszustands
DK1303632T3 (da) Galactomannan-oligosaccharid og fremgangsmåde til fremstilling samt anvendelse heraf
FI972164A0 (fi) Aerogeelipitoinen komposiittimateriaali, menetelmä sen valmistamiseksi ja sen käyttö
AU6245098A (en) Marking of products to extablish identity, source and fate
CA2145899A1 (en) Apparatus for transmitting and receiving executable application in a distributed computer system
MXPA03001711A (es) Metodo y sistema de evaluar comparativamente remuneraciones competitivas.
ZA988158B (en) Sulfinic acid derivatives and their preparation and use
DK0584136T3 (da) Bestemmelse af peptidmotiver på MHC-molekyler
BR9815208A (pt) Método e sistema para processamento de ambientes acústicos virtuais
BR0116969A (pt) método e sistema de gerenciamento de resìduo
NO974514D0 (no) Syntetisk HPV6/11 hydrud L1 DNA som koder for humant papillomavirus Type 11 L1-protein
PL340561A1 (en) Application of a combination of a converting enzyme inhibitor and a diuretic in treating microcirculatory disorders
JP2001526309A5 (https=)
BR9814486A (pt) Sistema para analisar o desempenho decontrolador de gráfico
ES2174951T3 (es) Composiciones desescamantes.
ATE319463T1 (de) Orale zubereitung mit seetang zur reduzierung von plaque und calculus
AU3436797A (en) Arrangement for operating two functionally parallel processors
ES2163001T3 (es) Nuevos derivados de borneol, procedimiento para su preparacion y su utilizacion farmaceutica.
DK0841937T4 (da) Anvendelse af betaglycan til reduktion af ardannelse
IT1304304B1 (it) Prodotti per l'igiene personale a base di estratti di lapachocontenenti quercetina ed eventuali altri chinoni presenti nel lapacho
MD1473G2 (ro) Remediu antiherpetic
FR2740772B1 (fr) Procede de preparation d'anthraquinones substituees et application a la preparation de rheines
DE69333222D1 (de) Verfahren und vorrichtung zur reduzierung des leistungsverbrauchs in einem öffentlichem fernsprechgerät
BR9800781A (pt) Processo e dispositibo para o acionamento de uma caixa de c‰mbio